vendredi 28 août 2015

Onco Actu du 28 août 2015

3.1 Tabac

FDA takes action against three tobacco manufacturers for making “additive-free” and/or “natural” claims on cigarette labeling [FDA]

E-cigarette ‘safety’ study was written by industry funded scientists, Lancet warns [The Telegraph]

Bill to regulate e-cigarettes clears California legislative hurdle [Reuters]

4. Dépistage, diagnostic et pronostic

2015-2019 Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence [ReportsnReports]

4.12 Biopsies liquides

MicroRNA Panel Shows Early Potential as Biomarker of Pancreatic Precancers [AACR]

More evidence that blood samples could help monitor breast cancer [Cancer Research UK]

4.9 Dép., diag. & prono. - Sein

Genetic Test Impacts Chemo Choices In Surprising Ways [TIME]

5. Traitements

Can a Modified Poliovirus Fight Advanced Prostate Cancer Too? [Duke]

Everything You Need to Know About Precision Medicine [Popular Science]

Let Fear Guide Early Stage Breast-Cancer Decisions [NY Times]

5.10 Traitements - Essais

Data Published in The New England Journal of Medicine Show Single-Agent Daratumumab Demonstrated a 36 Percent Overall Response Rate and Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients [Johnson & Johnson]

5.2.1 Pharma - Partenariats

Syndax, Genentech Launch Cancer Immunotherapy Trial Collaboration [GEN]

5.4 Traitements - Economie

Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate [FierceBiotech]

6.10 Politiques

Cancer, transplant patients protest over Venezuela's medicine shortages [Reuters]

6.11 Patients

Living With Cancer: Collateral Damage [NY Times]

6.8 Communication

To improve radiotherapy for patients, we need to improve its profile [Cancer Research UK]